Published in J Thorac Cardiovasc Surg on July 01, 2005
Oxidative Stress and Lung Ischemia-Reperfusion Injury. Oxid Med Cell Longev (2015) 0.91
Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury. J Immunol (2012) 0.91
Inhibition of pulmonary nuclear factor kappa-B decreases the severity of acute Escherichia coli pneumonia but worsens prolonged pneumonia. Crit Care (2013) 0.90
Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancer. Curr Gene Ther (2009) 0.86
Role of T cell-nuclear factor κB in transplantation. Transplant Rev (Orlando) (2011) 0.83
Endobronchial perfluorocarbon reduces inflammatory activity before and after lung transplantation in an animal experimental model. Mediators Inflamm (2013) 0.78
Linking gene expression, nuclear factor kappa B, remote ischemic preconditioning, and transplantation: a quest for an elusive Holy Grail or a road to an amazing discovery? J Thorac Cardiovasc Surg (2006) 0.77
Variable Ventilation Improved Respiratory System Mechanics and Ameliorated Pulmonary Damage in a Rat Model of Lung Ischemia-Reperfusion. Front Physiol (2017) 0.75
Experimental chronic kidney disease attenuates ischemia-reperfusion injury in an ex vivo rat lung model. PLoS One (2017) 0.75
Hypercapnic acidosis attenuates pulmonary epithelial stretch-induced injury via inhibition of the canonical NF-κB pathway. Intensive Care Med Exp (2016) 0.75
Aerosol-mediated delivery of AAV2/6-IκBα attenuates lipopolysaccharide-induced acute lung injury in rats. Hum Gene Ther (2015) 0.75
The role of ex vivo lung perfusion in lung transplantation. J Intensive Care Soc (2014) 0.75
Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med (2008) 4.70
Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med (2006) 2.69
Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. J Clin Invest (2006) 2.33
Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg (2002) 2.19
Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg (2010) 2.06
Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med (2004) 1.95
De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol (2008) 1.95
Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol (2011) 1.93
Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg (2002) 1.86
Long-term outcome of bilateral lung volume reduction in 250 consecutive patients with emphysema. J Thorac Cardiovasc Surg (2003) 1.80
Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. J Immunol (2009) 1.74
Cutting edge: Acute lung allograft rejection is independent of secondary lymphoid organs. J Immunol (2009) 1.64
Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells. J Immunol (2005) 1.61
Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation (2007) 1.54
Potential for detrimental hyperinflation after lung transplantation with application of negative pleural pressure to undersized lung grafts. J Thorac Cardiovasc Surg (2003) 1.54
Sternoclavicular joint infection: a comparison of two surgical approaches. Ann Thorac Surg (2011) 1.52
A prospective evaluation of lung volume reduction surgery in 200 consecutive patients. Chest (2003) 1.51
Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival. Eur J Cardiothorac Surg (2008) 1.50
Benefits of resection for metachronous lung cancer. J Thorac Cardiovasc Surg (2004) 1.50
Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum Immunol (2003) 1.50
Prevalence of benign disease in patients undergoing resection for suspected lung cancer. Ann Thorac Surg (2006) 1.46
Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat Biotechnol (2003) 1.46
The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation (2005) 1.46
Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J Clin Invest (2013) 1.42
Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transplant (2010) 1.41
Nonoperative management of large tracheal injuries. J Thorac Cardiovasc Surg (2008) 1.40
Results of lung volume reduction surgery in patients meeting a national emphysema treatment trial high-risk criterion. J Thorac Cardiovasc Surg (2004) 1.39
Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. J Heart Lung Transplant (2011) 1.37
Outcomes after resection of giant emphysematous bullae. Ann Thorac Surg (2004) 1.33
Maintenance of airway epithelium in acutely rejected orthotopic vascularized mouse lung transplants. Am J Respir Cell Mol Biol (2007) 1.33
Bronchial fenestration improves expiratory flow in emphysematous human lungs. Ann Thorac Surg (2003) 1.32
Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection. Ann Thorac Surg (2010) 1.32
Induction of IL-10 suppressors in lung transplant patients by CD4+25+ regulatory T cells through CTLA-4 signaling. J Immunol (2006) 1.31
Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am J Transplant (2005) 1.31
Orthotopic mouse lung transplantation as experimental methodology to study transplant and tumor biology. Nat Protoc (2009) 1.30
Lymph node evaluation in video-assisted thoracoscopic lobectomy versus lobectomy by thoracotomy. Ann Thorac Surg (2010) 1.29
Integration of transcriptional and posttranslational regulation in a glucose signal transduction pathway in Saccharomyces cerevisiae. Eukaryot Cell (2006) 1.27
Effects of CT section thickness and reconstruction kernel on emphysema quantification relationship to the magnitude of the CT emphysema index. Acad Radiol (2010) 1.26
Immunological link between primary graft dysfunction and chronic lung allograft rejection. Ann Thorac Surg (2008) 1.24
Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer. J Thorac Cardiovasc Surg (2006) 1.24
Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg (2002) 1.21
A simple, reproducible, and inexpensive technique in the preparation of explanted emphysematous lungs for ex vivo studies. J Thorac Cardiovasc Surg (2005) 1.16
Short- and long-term outcomes of 1000 adult lung transplant recipients at a single center. J Thorac Cardiovasc Surg (2010) 1.15
CD4+ T lymphocytes are not necessary for the acute rejection of vascularized mouse lung transplants. J Immunol (2008) 1.14
Outcomes and perception of lung surgery with implementation of a patient video education module: a prospective cohort study. J Am Coll Surg (2012) 1.13
Use of an apical heart suction device for exposure in lung transplantation. Ann Thorac Surg (2006) 1.13
Endoscopic ultrasound for early stage esophageal adenocarcinoma: implications for staging and survival. Ann Thorac Surg (2011) 1.12
Lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transplant (2004) 1.10
Oxidative damage to nucleic acids in severe emphysema. Chest (2008) 1.10
Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database. Ann Thorac Surg (2013) 1.10
Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease. Am J Transplant (2004) 1.09
Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761. J Thorac Cardiovasc Surg (2002) 1.08
Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer. J Thorac Cardiovasc Surg (2005) 1.06
A comprehensive molecular interaction map of the budding yeast cell cycle. Mol Syst Biol (2010) 1.06
Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial. Lung Cancer (2005) 1.05
Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant (2008) 1.05
National patterns of care and outcomes after combined modality therapy for stage IIIA non-small-cell lung cancer. J Thorac Oncol (2014) 1.05
Comparison of open subxiphoid pericardial drainage with percutaneous catheter drainage for symptomatic pericardial effusion. Ann Thorac Surg (2003) 1.03
Lung cancer resection combined with lung volume reduction in patients with severe emphysema. J Thorac Cardiovasc Surg (2004) 1.03
A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis. J Thorac Cardiovasc Surg (2011) 1.03
Feasibility and safety of the airway bypass procedure for patients with emphysema. J Thorac Cardiovasc Surg (2003) 1.02
Distinct mechanisms for spiro-carbon formation reveal biosynthetic pathway crosstalk. Nat Chem Biol (2013) 1.02
Macrophage chitinase 1 stratifies chronic obstructive lung disease. Am J Respir Cell Mol Biol (2009) 1.02
Cigarette smoke induces nucleic-acid oxidation in lung fibroblasts. Am J Respir Cell Mol Biol (2009) 1.01
Different kinetics of obliterative airway disease development in heterotopic murine tracheal allografts induced by CD4+ and CD8+ T cells. Transplantation (2002) 1.00
IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction. Am J Respir Crit Care Med (2006) 1.00
Treatment of malignant pleural effusion: a cost-effectiveness analysis. Ann Thorac Surg (2012) 0.99
Identification of dosage-sensitive genes in Saccharomyces cerevisiae using the genetic tug-of-war method. Genome Res (2012) 0.99
Acute health care resource utilization for ileostomy patients is higher than expected. Dis Colon Rectum (2014) 0.99
Respiratory virus-induced dysregulation of T-regulatory cells leads to chronic rejection. Ann Thorac Surg (2010) 0.98
Reliability for grading acute rejection and airway inflammation after lung transplantation. J Heart Lung Transplant (2005) 0.98
Establishing a new methodology for genome mining and biosynthesis of polyketides and peptides through yeast molecular genetics. Chembiochem (2012) 0.98
Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival. Ann Thorac Surg (2002) 0.97
The predictive value of bronchiolitis obliterans syndrome stage 0-p. Am J Respir Crit Care Med (2003) 0.97
Inhibition of obliterative airway disease development in murine tracheal allografts by matrix metalloproteinase-9 deficiency. Am J Transplant (2005) 0.97
Endobronchial gene transfer of soluble type I interleukin-1 receptor ameliorates lung graft ischemia-reperfusion injury. Ann Thorac Surg (2004) 0.96
Adult lung transplantation: technical considerations. Semin Thorac Cardiovasc Surg (2008) 0.95
Fragilities caused by dosage imbalance in regulation of the budding yeast cell cycle. PLoS Genet (2010) 0.95
Effects of diffusion time on short-range hyperpolarized (3)He diffusivity measurements in emphysema. J Magn Reson Imaging (2009) 0.95
Primary graft dysfunction and other selected complications of lung transplantation: A single-center experience of 983 patients. J Thorac Cardiovasc Surg (2005) 0.94
Plasmid construction using recombination activity in the fission yeast Schizosaccharomyces pombe. PLoS One (2010) 0.93
Elevated soluble CD30 correlates with development of bronchiolitis obliterans syndrome following lung transplantation. Transplantation (2006) 0.93
Orthotopic vascularized right lung transplantation in the mouse. J Thorac Cardiovasc Surg (2010) 0.93
Completion pneumonectomy: outcomes for benign and malignant indications. Ann Thorac Surg (2013) 0.93
Concomitant allorecognition of mismatched donor HLA class I- and class II-derived peptides in pediatric lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant (2003) 0.92
Concomitant coronary artery revascularization to allow successful lung transplantation in selected patients with coronary artery disease. J Thorac Cardiovasc Surg (2002) 0.92
Impact of video-assisted thoracoscopic surgery on benign resections for solitary pulmonary nodules. Ann Thorac Surg (2011) 0.92
Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant (2010) 0.92
Clinical-pathologic conference in general thoracic surgery: Cardiac lymphoma. J Thorac Cardiovasc Surg (2005) 0.91
Intralobar pulmonary sequestration associated with an aneurysmal aberrant aortic branch. J Thorac Cardiovasc Surg (2007) 0.91
Tumor location is not an independent prognostic factor in early stage non-small cell lung cancer. Ann Thorac Surg (2010) 0.90
Technical considerations in lung transplantation. Chest Surg Clin N Am (2003) 0.90
A positive return on investment: research funding by the Thoracic Surgery Foundation for Research and Education (TSFRE). J Thorac Cardiovasc Surg (2011) 0.89
Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients. J Heart Lung Transplant (2010) 0.88
Lung transplantation and donation after cardiac death: a single center experience. Ann Thorac Surg (2009) 0.88
Lung transplantation for pulmonary vascular disease. Ann Thorac Surg (2002) 0.88
A genome-wide activity assessment of terminator regions in Saccharomyces cerevisiae provides a ″terminatome″ toolbox. ACS Synth Biol (2013) 0.88
Animal models for bronchiolitis obliterans syndrome following human lung transplantation. Immunol Res (2005) 0.88